MMP9 and glioblastoma: A separate analysis comparing newly diagnosed glioblastoma (ndGBM) patients with recurrent glioblastoma (rGBM) patients revealed a significant difference in OS but no significant differences in intra-tumoral or secreted MMP-9 levels or activity (Figure 5), which was elevated in both subgroups.